Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Greg
    Member
    • Oct 2009
    • 31

    alternative splicing quantification and comparison with RNAseq

    As there is no consensus in the literature on this I thought it might be worth it to try to generate some discussion here. I am interested in finding quantitative changes in alternative splicing (AS) across different genotypes or treatments. I am only interested in events and not isoforms. Essentially there are 3 main areas to deal with;

    1) What to count. Split reads are tempting but make up a very small portion of the total aligned reads, so using only them you lose a lot of information and may suffer from more stochastic coverage. Read count in exons or introns has been used but what about reads that fall into both an exon or intron (thinking about intron retention in plants)? If you remove these detection of small sites, like alternative 5' or 3' sites may suffer. Has anyone thought of using a nt count approach?

    2) How to normalize How should one correct for different expression levels of genes (if you are only interested in finding different AS)? How to deal with different coverage in your different libraries? I've been using total number of reads to the gene vs the number in the exon/intron of interest.

    3) How to compare What stats are people using? ANOVA has been used by Harr and Turner. What about using a binomial or negative binomial? Could using the DESeq package for this be reasonable (send it read counts for all the exons/introns of one gene and find ones that are differentially expressed as oppose to sending it all the genes in a genome)?

    I know that is a lot of questions for one post but you (might) know the fishermans saying "Good things come to those who bait".

    1. Harr B, Turner LM. Genome-wide analysis of alternative splicing evolution among Mus subspecies. Molecular ecology. 2010;19 Suppl 1:228-39. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20331782.
  • Greg
    Member
    • Oct 2009
    • 31

    #2
    Not even a nibble?

    Comment

    • hlwright
      Member
      • Feb 2011
      • 30

      #3
      I am interested in looking at the possibility of detecting alternative splicing from SOLiD transcriptome data (human). I thought posting a reply on this thread would be a good way to bring this back to people's attention as I see there were no takers back in 2009.

      I am a beginner so would like to know if there are open source tools available which could analyse my data in this way.

      Thanks
      Helen

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
        The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
        Whether you're exploring Kheloyaar for the first time or want to understand...
        Yesterday, 09:27 PM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        Yesterday, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:04 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...